Harmony Biosciences (HRMY) News Today $30.97 -1.56 (-4.80%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$30.03 -0.94 (-3.03%) As of 04/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of DirectorsApril 3 at 8:05 AM | businesswire.comKLP Kapitalforvaltning AS Invests $791,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)KLP Kapitalforvaltning AS purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,000 shares of theApril 2 at 3:49 AM | marketbeat.comHighTower Advisors LLC Has $392,000 Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)HighTower Advisors LLC reduced its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 85.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,401 shares of the coApril 2 at 3:23 AM | marketbeat.com49,632 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Bought by New Age Alpha Advisors LLCNew Age Alpha Advisors LLC acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 49,632 shares of the compaApril 1 at 4:30 AM | marketbeat.comHarmony Biosciences to Present at 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | msn.comAmerican Century Companies Inc. Increases Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)American Century Companies Inc. grew its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,102,604 shares of theMarch 29, 2025 | marketbeat.comBronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Stockholders to ConnectMarch 28, 2025 | markets.businessinsider.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Swiss National BankSwiss National Bank boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 78,200 shares of the company's stock after purchasingMarch 28, 2025 | marketbeat.comMizuho Securities Sticks to Their Buy Rating for Harmony Biosciences Holdings (HRMY)March 28, 2025 | markets.businessinsider.comHarmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare ConferenceMarch 26, 2025 | businesswire.comEntryPoint Capital LLC Makes New Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)EntryPoint Capital LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 32,084 shares of the company's stock, vaMarch 26, 2025 | marketbeat.comProficio Capital Partners LLC Invests $367,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Proficio Capital Partners LLC bought a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,667 shares oMarch 26, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Shares Down 3.2% - Time to Sell?Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 3.2% - Time to Sell?March 25, 2025 | marketbeat.comHarmony Biosciences: A Compelling Risk-Reward OpportunityMarch 24, 2025 | seekingalpha.comHarmony Biosciences CCO Jeffrey Dierks steps down, Adam Zaeske succeedsTakedaMarch 24, 2025 | markets.businessinsider.comHarmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio ExpandsMarch 24, 2025 | businesswire.comBridge City Capital LLC Increases Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Bridge City Capital LLC raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 103,809 shares of the company's stock after acquiring an additional 22,7March 24, 2025 | marketbeat.comSummit Global Investments Boosts Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Summit Global Investments lifted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 57.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,290 shares of the company's stock aftMarch 24, 2025 | marketbeat.comHRMY Investors Have Opportunity to Join Harmony Biosciences Holdings, Inc. Fraud Investigation with the Schall Law FirmMarch 21, 2025 | businesswire.comAmundi Acquires 13,041 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Amundi raised its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 243.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 18,402 shares of the company's stock after purMarch 21, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 100,586 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Charles Schwab Investment Management Inc. grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 27.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 472,028 shares of the coMarch 21, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Price Target Raised to $44.00Mizuho raised their target price on shares of Harmony Biosciences from $42.00 to $44.00 and gave the stock an "outperform" rating in a report on Tuesday.March 19, 2025 | marketbeat.comExpert Outlook: Harmony Biosciences Hldgs Through The Eyes Of 11 AnalystsMarch 18, 2025 | benzinga.comHarmony Biosciences price target raised to $44 from $42 at MizuhoMarch 18, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc. - HRMYMarch 17, 2025 | prnewswire.comVictory Capital Management Inc. Has $5.05 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Victory Capital Management Inc. grew its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 112.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 146,609 shMarch 16, 2025 | marketbeat.comAurora Investment Counsel Invests $2.11 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Aurora Investment Counsel purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 61,293 shares of the company's sMarch 15, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Bank of New York Mellon CorpBank of New York Mellon Corp boosted its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 13.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 265,639 shares of the company's stock after purchasingMarch 15, 2025 | marketbeat.comAlphaQuest LLC Sells 22,625 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)AlphaQuest LLC lowered its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 63.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,098 shares of the company's stock after selling 22,625 shMarch 14, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Consensus Rating of "Buy" from BrokeragesShares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have earned an average rating of "Buy" from the nine ratings firms that are presently covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy rating. The average 12March 13, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc. - HRMYMarch 11, 2025 | prnewswire.comProficio Capital Partners LLC Buys New Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Proficio Capital Partners LLC purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 10,667 shares of the company's stock, valued at approximately $367,000. SMarch 11, 2025 | marketbeat.comHarmony Biosciences to Present at Upcoming Global Healthcare ConferencesMarch 10, 2025 | msn.comRuffer LLP Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Ruffer LLP acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 75,501 shares of the company's stock, valuedMarch 10, 2025 | marketbeat.comCapital Management Corp VA Increases Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Capital Management Corp VA boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 43.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 340,960 shares of the company's stock after buying anMarch 9, 2025 | marketbeat.comHarmony Biosciences to Participate in Upcoming Investor ConferencesMarch 4, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc. - HRMYMarch 3, 2025 | prnewswire.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Principal Financial Group Inc.Principal Financial Group Inc. boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 208,663 shares of tMarch 3, 2025 | marketbeat.comNew York State Common Retirement Fund Purchases 14,406 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)New York State Common Retirement Fund boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 30.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 61,878 sMarch 2, 2025 | marketbeat.comCantor Fitzgerald Has Negative View of HRMY FY2025 EarningsHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Investment analysts at Cantor Fitzgerald lowered their FY2025 earnings per share estimates for Harmony Biosciences in a research report issued to clients and investors on Wednesday, February 26th. Cantor Fitzgerald analyst C. DuncanMarch 1, 2025 | marketbeat.comRhumbline Advisers Buys 16,537 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Rhumbline Advisers raised its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 18.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,588 shares of thMarch 1, 2025 | marketbeat.comHC Wainwright Cuts Harmony Biosciences (NASDAQ:HRMY) Price Target to $70.00HC Wainwright decreased their target price on Harmony Biosciences from $75.00 to $70.00 and set a "buy" rating on the stock in a research report on Thursday.February 28, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Y Intercept Hong Kong LtdY Intercept Hong Kong Ltd raised its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 287.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,061 shares of the company's stock after purchasing an adFebruary 28, 2025 | marketbeat.comHarmony Biosciences price target lowered to $70 from $75 at H.C. WainwrightFebruary 27, 2025 | markets.businessinsider.comHarmony Biosciences (NASDAQ:HRMY) Trading Down 8.2% - Here's WhyHarmony Biosciences (NASDAQ:HRMY) Shares Down 8.2% - Should You Sell?February 27, 2025 | marketbeat.comIs Harmony Biosciences Holdings, Inc. (HRMY) the Best Small-Cap Growth Stock to Buy Now?February 26, 2025 | insidermonkey.comHarmony Biosciences price target raised to $33 from $31 at BofAFebruary 26, 2025 | markets.businessinsider.comHarmony Biosciences Holdings (HRMY) Receives a Rating Update from a Top AnalystFebruary 26, 2025 | markets.businessinsider.comHarmony Biosciences (HRMY) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | msn.comHarmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...February 26, 2025 | finance.yahoo.com Remove Ads Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address HRMY Media Mentions By Week HRMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼0.970.61▲Average Medical News Sentiment HRMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼86▲HRMY Articles Average Week Remove Ads Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Roivant Sciences News Lantheus News BridgeBio Pharma News Revolution Medicines News Legend Biotech News TG Therapeutics News Sarepta Therapeutics News Axsome Therapeutics News Blueprint Medicines News Telix Pharmaceuticals Limited American Depositary Shares News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HRMY Stock Free HRMY Stock Alerts